This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
1g | $350 | In Stock |
2g | $500 | In Stock |
5g | $770 | In Stock |
Cat #: V1603 CAS #: 33069-62-4 Purity ≥ 98%
Description: Paclitaxel (also known as NSC-125973; BMS-181339-01; trade name taxol; Anzatax; Asotax; Bristaxol) is a highly potent microtubule polymer stabilizer (mitotic inhibitor that stabilizes the polymerization of tubulin) with an IC50 of 0.1 pM in human endothelial cells.=
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 853.91 |
---|---|
Molecular Formula | C47H51NO14 |
CAS No. | 33069-62-4 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 171 mg/mL (200.3 mM)r |
Water:<1 mg/mLr | |
Ethanol: 18 mg/mL (21.1 mM) | |
Solubility In Vivo | 1% DMSO+30% polyethylene glycol+1% Tween 80: 30 mg/mL |
Synonyms | NSC 125973; BMS 181339-01; NSC-125973; BMS181339-01; NSC125973; BMS-181339-01; Trade name: Taxol; Taxol Konzentrat; Anzatax; Asotax; Bristaxol; Praxel; TAX. Chemical Name: (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate SMILES Code: O=C1[C@H](OC(C)=O)C(C2(C)C)=C(C)[C@@H](OC([C@H](O)[C@@H](NC(C3=CC=CC=C3)=O)C4=CC=CC=C4)=O)C[C@@]2(O)[C@@H](OC(C5=CC=CC=C5)=O)[C@@]6([H])[C@@]1(C)[C@@H](O)C[C@@]7([H])OC[C@]76OC(C)=O Exact Mass: 853.33096 |
Protocol | In Vivo | Paclitaxel (1 -20 mg/kg; intraperitoneal injection; 1 time/2 days, 5 cycles) Liver metastases were significantly induced in the low paclitaxel group and had little effect on primary tumor growth |
---|---|---|
Animal model | MDA-231 xenograft-bearing mice | |
Dosages | 1, 20 mg/kg | |
Administration | Intraperitoneal injection; five cycles (1 time/2 days) |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.1711 mL | 5.8554 mL | 11.7108 mL | 23.4217 mL |
5mM | 0.2342 mL | 1.1711 mL | 2.3422 mL | 4.6843 mL |
10mM | 0.1171 mL | 0.5855 mL | 1.1711 mL | 2.3422 mL |
20mM | 0.0586 mL | 0.2928 mL | 0.5855 mL | 1.1711 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.